Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective December 16, 2022, Nicole Kelsey will no longer serve as Chief Legal
Officer and Secretary of Amyris, Inc. (the "Company"). Ms. Kelsey's departure is
not related to any legal, compliance or other matters of the Company. Upon a
release of claims in the Company's favor, Ms. Kelsey is eligible to receive a
severance payment (including base salary and health benefits) as described in
her offer letter, which is filed as Exhibit 10.75 to the Company's Annual Report
on Form 10-K for the year ended December 31, 2017, and which descriptions are
incorporated herein by reference.
On December 16, 2022, the Company appointed Doris Choi, 44, General Counsel and
Secretary, reporting to Han Kieftenbeld, the Company's Chief Financial and
Administration Officer. Ms. Choi has served as Vice President, Senior Corporate
Counsel since joining the Company in December 2020. She brings over 15 years of
corporate law experience in private practice and in-house positions, including
most recently, as Senior Corporate Counsel at Jazz Pharmaceuticals, a
Nasdaq-listed global biopharmaceutical company, from August 2016 to December
2020, and as Associate General Counsel and Assistant Secretary at QuinStreet, a
Nasdaq-listed performance marketing technology company, from March 2014 to
August 2016. She started her career in private practice as an associate at
Latham & Watkins LLP focused on corporate and finance transactions, from
September 2005 to May 2010. Ms. Choi received a B.A. from Northwestern
University, an M.A. from University of Chicago and a J.D. from Columbia
University.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. Description
104 Cover Page Interactive Data File (embedded within the Inline XBRL
document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses